PIKFYVE antisense oligonucleotides
US12104159B2 · kind B2 · utility
0Cited by
23References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2022 |
| Grant date | Oct 1, 2024 |
| Priority date | — |
| Expiry date | Jun 22, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/0115
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to PIKFYVE antisense oligonucleotides (ASOs), pharmaceutical compositions containing them, and methods for treating, inhibiting, suppressing, and preventing neurological diseases with them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.